S1PR1 and glioblastoma: In addition, Fingolimod (FTY720), a functional antagonist of S1PR1, is able to slow the growth of intracranial xenograft tumors in nude mice, augments the therapeutic effect of the cytostatic temozolomide and has a strong antiproliferative impact on GBM cells [20,21].